Emerging therapies against Naegleria fowleri

IF 0.8 4区医学 Q4 PHARMACOLOGY & PHARMACY

Expert Opinion on Orphan Drugs Pub Date : 2024-07-31 DOI:10.1080/21678707.2024.2383173

Ruqaiyyah Siddiqui, David Lloyd, Ahmad M. Alharbi, Naveed Ahmed Khan

引用次数: 0

Abstract

Naegleria fowleri is a free-living protist pathogen. Given the opportunity, it can produce infection of the central nervous system. It is distressing that the brain-eating amoebae, Naegleria fowler...

查看原文本刊更多论文

针对奈格勒氏菌的新疗法

奈格勒氏菌是一种自由生活的原生病原体。只要有机会，它就会感染中枢神经系统。令人痛心的是，食脑阿米巴原虫...

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Opinion on Orphan Drugs PHARMACOLOGY & PHARMACY-

CiteScore

2.30

自引率

0.00%

发文量

期刊介绍： Expert Opinion on Orphan Drugs is an international, peer-reviewed journal that covers all aspects of R&D on rare diseases and orphan drugs.